Ascentage Pharma Group International (HK:6855) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Ascentage Pharma Group International has officially announced the composition of its board of directors and three key board committees. The board is chaired by Executive Director Dr. Yang Dajun, with a mix of non-executive and independent non-executive directors including Dr. Wang Shaomeng, Dr. Lu Simon Dazhong, Mr. Ye Changqing, Mr. Ren Wei, and Dr. David Sidransky. The announcement details the members and chairpersons of the Audit, Remuneration, and Nomination Committees, crucial for the company’s governance.
For further insights into HK:6855 stock, check out TipRanks’ Stock Analysis page.